Cancer stem cells: Bridging microenvironmental interactions and clinical therapy
Clinical and Translational Medicine · 2025-07 · 15 (7)
DOI: 10.1002/ctm2.70406 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 15.07.2025. Verfasst von Huiling Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, People's R…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Tumor Microenvironment. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Youth Science and Technology Foundation, Sichuan University Interdisciplinary Innovation Fund, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Cancer stem cells (CSCs) are a core subpopulation of tumour tissues exhibiting stem cell properties. Although they constitute only a minority of tumour cells, CSCs have become a central force driving tumourigenesis, metastasis, recurrence and resistance to therapy, owing to their abilities for self‐renewal, multi‐lineage differentiation and tumour‐initiating ability. Recent advances in multi‐omics analysis, lineage tracing and single‐cell sequencing technologies have systematically elucidated the dynamic biology of CSCs, including their epigenetic plasticity, metabolic adaptations and phenotypic heterogeneity, which depend on their ecological niche. In this review, we summarise the biological properties of CSCs, the molecular regulatory mechanisms and the complex interactions with the tumour microenvironment. We focus on strategies to target CSCs and the clinical translational challenges associated with these approaches. Collectively, this review organically integrates basic mechanisms and clinical translational research on CSCs, offering a comprehensive framework for understanding tumour biology and developing precision therapeutic strategies. Highlights Systems integration of CSC biology: Elucidate the dynamic properties, self‐renewal, plasticity and drug resistance. Microenvironmental interactions: Bidirectional interactions between CSCs and other cells, providing insights into niche‐driven immune evasion and metastasis. Therapeutic strategies: Evaluate emerging therapies targeting CSC‐specific markers and signals. Future directions: Challenges are discussed, with proposed solutions including multi‐omics‐guided precision medicine and microenvironment remodelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
ORCID-Profile: Hongxin Deng
Förderung
- Sichuan Provincial Youth Science and Technology Foundation
- Sichuan University Interdisciplinary Innovation Fund
- West China Hospital, Sichuan University
Zitieren
APA
Wang, H., Li, J., Du, F., & Deng, H. (2025). Cancer stem cells: Bridging microenvironmental interactions and clinical therapy. Clinical and Translational Medicine, 15(7). https://doi.org/10.1002/ctm2.70406
Vancouver
Wang H, Li J, Du F, Deng H. Cancer stem cells: Bridging microenvironmental interactions and clinical therapy. Clinical and Translational Medicine. 2025;15(7). doi:10.1002/ctm2.70406
BibTeX
@article{Wang2025,
author = {Wang, Huiling and Li, Junshu and Du, Fei and Deng, Hongxin},
title = {Cancer stem cells: Bridging microenvironmental interactions and clinical therapy},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {7},
doi = {10.1002/ctm2.70406}
}
EUVIMED